HIV and aging: A clinical journey from Koch's postulate to the chronic disease model and the contribution of geriatric syndromes

Current Opinion in HIV and AIDS

Volumn 9, Issue 4, 2014, Pages 405-411

  Chirch, Lisa M ^a   Hasham, Mohamed ^a   Kuchel, George A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

AIDS; disability; elderly; frailty; geriatric

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ;

AGING; CHRONIC DISEASE; DISABILITY; DIZZINESS; GERIATRIC DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDEPENDENCE; LONGEVITY; MORBIDITY; OUTCOME ASSESSMENT; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVOR; COMORBIDITY; HIV INFECTIONS;

AGING; CHRONIC DISEASE; COMORBIDITY; HIV INFECTIONS; HUMANS;

EID: 84902298002     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000074     Document Type: Review

References (61)

1. Weiss RA. Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges. Clin Exp Immunol 2008; 152:201-210.
2. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988; 10 (Suppl 2):S274-S276.
3. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep 2010; 7:69-76.
4. Greene M, Justice AC, Lampiris HW, Valcour V. Management of human immunodeficiency virus infection in advanced age. JAMA 2013; 309:1397-1405.
5. High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012; 60 (Suppl 1); S1-18.
6. Work Group for the HIV and Aging Consensus Project (2012). Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc 2012; 60:974-979.
7. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002; 288:1775-1779.
8. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA 2002; 288:1909-1914.
9. Barr VJ, Robinson S, Marin-Link B, et al. The expanded Chronic Care Model: an integration of concepts and strategies from population health promotion and the Chronic Care Model. Hosp Q 2003; 7:73-82.
10. Salive ME. Multimorbidity in older adults. Epidemiol Rev 2013; 35:75-83.
11. Tinetti ME, Fried TR, Boyd CM. Designing healthcare for the most common chronic condition-multimorbidity. JAMA 2012; 307:2493-2494.
12. Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet 2013; 381:752-762.
13. Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med 2011; 27:1-15.
14. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007; 55:780-791.
15. Tinetti ME, Inouye SK, Gill TM, Doucette JT. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 1995; 273:1348-1353.
16. Allore HG, Tinetti ME, Gill TM, Peduzzi PN. Experimental designs for multicomponent interventions among persons with multifactorial geriatric syndromes. Clin Trials 2005; 2:13-21.
17. Morgan EE, Iudicello JE, Weber E, et al. Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr 2012; 61:341-348.
18. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-155.
19. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol 2012; 24:501-506.
20. Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2013; 1-10.
21. Martin J, Volberding P. HIV and premature aging: a field still in its infancy. Ann Intern Med 2010; 153:477-479.
22. Tchkonia T, Zhu Y, van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 2013; 123:966-972.
23. Ferrucci L, Ble A, Bandinelli S, et al. A flame burning within. Aging Clin Exp Res 2004; 16:240-243.
24. Neuhaus J, Jacobs DR Jr, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201:1788-1795.
25. Duprez DA, Neuhaus J, Kuller LH, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One 2012; 7:e44454.
26. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
27. Baker JV, Neuhaus J, Duprez D, et al. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr 2011; 56:36-43.
28. Hearps AC, Martin GE, Rajasuriar R, Crowe SM. Inflammatory co-morbidities in HIV individuals: learning lessons from healthy ageing. Curr HIV/AIDS Rep 2014; 11:20-34.
29. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 2007; 25:3066-3069.
30. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008; 47:542-553.
31. Schmaltz HN, Fried LP, Xue QL, et al. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc 2005; 53:747-754.
32. Kuchel GA. Aging and homeostatic regulation. In: Halter JB, Hazzard WR, Ouslander JG, Tinetti ME, Wolard N, Studenski S, High K, Asthana S, editors. Hazzard's principles of geriatric medicine and gerontology, 6th ed. New York: McGraw Hill; 2010. pp. 621-630.
33. Flacker JM. What is a geriatric syndrome anyway? J Am Geriatr Soc 2003; 51:574-576.
34. Cappola AR, Xue QL, Ferrucci L, et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003; 88:2019-2025.
35. Kositsawat J, Barry LC, Kuchel GA. C-reactive protein, vitamin D deficiency, and slow gait speed. J Am Geriatr Soc 2013; 61:1574-1579.
36. Wang HX, Gustafson DR, Kivipelto M, et al. Education halves the risk of dementia due to apolipoprotein epsilon4 allele: a collaborative study from the Swedish brain power initiative. Neurobiol Aging 2012; 33:1007.
37. Edelman EJ, Gordon KS, Glover J, et al. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging 2013; 30:613-628.
38. de Waal R, Cohen K, Maartens G. Systematic review of antiretroviral- associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS One 2013; 8:e63623.
39. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012; 308:387-402.
40. Friis-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-1735.
41. Tanaka H, Arai M, Tomoda Y, et al. Evaluation of renal adverse effects of combination antiretroviral therapy including tenofovir in HIV-infected patients. J Pharm Pharm Sci 2013; 16:405-413.
42. Schafer JJ, Manlangit K, Squires KE. Bone health and human immunodeficiency virus infection. Pharmacotherapy 2013; 33:665-682.
43. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53:1120-1126.
44. Desquilbet L, Jacobson LP, Fried LP, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007; 62:1279-1286.
45. Chu C, Selwyn PA. Complications of HIV infection: a systems-based approach. Am Fam Physician 2011; 83:395-406.
46. Chu C, Selwyn PA. An epidemic in evolution: the need for new models of HIV care in the chronic disease era. J Urban Health 2011; 88:556-566.
47. Tinetti ME, Studenski SA. Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med 2011; 364:2478-2481.
48. Sandkovsky U, Robertson KR, Meza JL, et al. Pilot study of younger and older HIV-infected adults using traditional and novel functional assessments. HIV Clin Trials 2013; 14:165-174.
49. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146-M156.
50. Desquilbet L, Jacobson LP, Fried LP, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci 2011; 66:1030-1038.
51. Desquilbet L, Margolick JB, Fried LP, et al. Relationship between a frailtyrelated phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009; 50:299-306.
52. Baumgartner RN, Wayne SJ, Waters DL, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004; 12:1995-2004.
53. Shah K, Hilton TN, Myers L, et al. A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus. J Am Geriatr Soc 2012; 60:545-549.
54. Ruiz M, Cefalu C. Characteristics of frail patients in a geriatric-HIV program: the experience of an urban academic center at one year follow-up. J Int Assoc Physicians AIDS Care (Chic) 2011; 10:138-143.
55. Bauer LO, Wu Z, Wolfson LI. An obese body mass increases the adverse effects of HIV/AIDS on balance and gait. Phys Ther 2011; 91:1063-1071.
56. Ruiz MA, Reske T, Cefalu C, Estrada J. Falls in HIV-infected patients: a geriatric syndrome in a susceptible population. J Int Assoc Provid AIDS Care 2013; 12:266-269.
57. Erlandson KM, Allshouse AA, Jankowski CM, et al. Risk factors for falls in HIVinfected persons. J Acquir Immune Defic Syndr 2012; 61:484-489.
58. Rees HC, Ianas V, McCracken P, et al. Measuring frailty in HIV-infected individuals. Identification of frail patients is the first step to amelioration and reversal of frailty. J Vis Exp 2013; 77:1-5.
59. Ianas V, Berg E, Mohler MJ, et al. Antiretroviral therapy protects against frailty in HIV-1 infection. J Int Assoc Provid AIDS Care 2013; 12:62-66.
60. Souza PM, Jacob-Filho W, Santarem JM, et al. Effect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls. Clinics (Saõ Paulo) 2011; 66:261-266.
61. Souza PM, Jacob-Filho W, Santarem JM, et al. Progressive resistance training in elderly HIV-positive patients: does it work? Clinics (Saõ Paulo) 2008; 63:619-624.